Today’s stock market coverage illustrates two very different kinds of momentum. NeOnc (NASDAQ:NTHI), MDxHealth (NASDAQ:MDXH), and Capricor Therapeutics (NASDAQ:CAPR) are fundamentally driven healthcare stories, where clinical data, regulatory decisions, diagnostics adoption and cash runway determine whether today's enthusiasm can become a durable rerating, while Wetour Robotics (NASDAQ:WETO), Onfolio Holdings (NASDAQ:ONFO), and Creative Global Technology Holdings (NASDAQ: CGTL) are much more structure-sensitive.

Austin, Texas, August 14th, 2026, FinanceWire

SS Innovations International (NASDAQ: SSII) reported record second-quarter 2026 revenue of $13.9 million, up 39.4% from $10 million a year earlier, as installations of its SSi Mantra surgical robotic system increased 30.4% to 30. Gross profit rose 20% to $7.1 million, with gross margin of 50.9%, while net loss was $2.7 million, or $0.01 per […]

Aging populations are pushing joint disease higher on the orthopedic agenda, with cartilage damage representing one of the field’s largest unmet needs. Current treatments have demonstrated clinical utility, but they remain difficult to deliver efficiently and economically on scale. That gap is where off-the-shelf therapies can deliver high value, and where manufacturing know-how and intellectual […]